Similarly, patients with HCC tumors expressing low STYK1 levels showed significantly longer disease-free survival (DFS) than those expressing high STYK1 levels (p < 0.0001) (Fig. 1D). The gene discussed is STYK1; the disease is hepatocellular carcinoma.